// App-Quantinova.ai

P381 : Infliximab induction regimes in steroid refractory acute severe colitis: a multi-centre retrospective cohort study with propensity score analysis

Researchers

Presenter

  • S Sebastian

Principal Investigators

  • N Syed

  • K Argyriou

  • G Martin

  • L Los

  • J Fiske

  • R Ranjan

  • B Cooper

  • N Patel

  • V Goodoory

  • F Shaikh

  • H L Ching

  • N Jayasooriya

  • J Brooks

  • A Dhar

  • A H Shenoy

  • J Limdy

  • J Butterworth

  • P B Allen

  • S Samuel

  • G Moran

  • R Shenderey

  • G Parkes

  • A Lobo

  • S Subramanian

  • T Raine

Medical Centers

  • IBD Unit, Hull and East Yorkshire Hospitals NHS Trust, Hull, UK

  • Hull York Medical School, University of Hull and York, Hull, UK

  • Nottingham University City Hospital NHS Trust, Nottingham, United Kingdom

  • South Eastern Trust, Belfast, UK

  • Royal Shrewsbury Hospitals NHS Trust, Shrewsbury, UK

  • Pennine Acute Hospitals NHS Trust, Manchester, United Kingdom

  • County Durham and DarlingtonNHS Foundation Trust, County Durham, UK

  • Colchester Hospital University NHS Trust, Colchester, United Kingdom

  • Royal Liverpool and Broardgreen University Hospital NHS Trust, Liverpool, United Kingdom

  • Airedale NHS Foundation Trust, Airedale, UK

  • Sheffield Teaching Hospitals, Sheffiled, UK

  • Royal London Hospital, Barts Health NHS Trust, London, UK

  • Addenbrooke's Hospital, University of Cambridge, Cambridge, , United Kingdom

  • Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Ulcerative colitis

Biomarkers

  • C reactive protein

  • Human albumin

Drug/Treatment

  • Infliximab

Outcome

  • N/A

Study Design

  • Multicenteric

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved